Antitryptic property of cancer-related glycoprotein EDC1

Cancer Res. 1978 Feb;38(2):452-7.

Abstract

Cancer-related urinary glycoprotein EDC1 inhibits the action of trypsin and chymotrypsin on casein and synthetic substrates. The amino acid and carbohydrate compositions of EDC1 are different from those reported for pregnancy-related urinary trypsin inhibitors.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Carboxypeptidases / antagonists & inhibitors
  • Caseins
  • Chymotrypsin
  • Fibrinolysin / antagonists & inhibitors
  • Glycoproteins / urine*
  • Humans
  • Leucyl Aminopeptidase / antagonists & inhibitors
  • Neoplasms / urine*
  • Pancreatic Elastase / antagonists & inhibitors
  • Pepsin A / antagonists & inhibitors
  • Protein Binding
  • Tosyl Compounds
  • Trypsin Inhibitors / urine*
  • Tyrosine

Substances

  • Caseins
  • Glycoproteins
  • Tosyl Compounds
  • Trypsin Inhibitors
  • Tyrosine
  • Carboxypeptidases
  • Leucyl Aminopeptidase
  • Chymotrypsin
  • Pancreatic Elastase
  • Fibrinolysin
  • Pepsin A